Abstract
This study sought to evaluate the impact of 99mTcO and 99mTc≡N cores on the physicochemical and biodistribution properties of 99mTc-labelled complexes of pamidronate dithiocarbamate. We successfully converted the commercially available pamidronate to pamidronate dithiocarbamate (PAMDTC) and its 99mTc-labelled complexes were prepared with high radiochemical yield (97.95 ± 0.59% and 97.66 ± 1.53% for 99mTcN-PAMDTC and 99mTcO-PAMDTC, respectively). Both complexes were stable in vitro. The partition coefficient results showed that both of them were hydrophilic and 99mTcN-PAMDTC exhibited more hydrophilic than 99mTcO-PAMDTC. The binding rate of 99mTcN-PAMDTC to human serum albumin was lower than that of 99mTcO-PAMDTC. 99mTcN-PAMDTC performed better affinity to hydroxyapatite than 99mTcO-PAMDTC. From the biodistribution study results, 99mTcN-PAMDTC showed higher bone uptake and ratios of bone/blood and bone/muscle at 4 h post-injection. Further, single photon emission computed tomography (SPECT) imaging study of 99mTcN-PAMDTC showed that there was a clear accumulation in bone, suggesting it would be a potential novel bone imaging agent. It was concluded that different 99mTc cores had an important impact on the physicochemical and biological properties of 99mTc-labelled complexes of pamidronate dithiocarbamate.
Similar content being viewed by others
References
Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66
Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271–278
Selvaggi G, Scagliotti GV (2005) Management of bone metastases in cancer: a review. Crit Rev Oncol Hematol 56:365–378
Blake GM, Park-Holohan S-J, Cook GJR, Fogelman I (2001) Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med 31:28–49
Shigematsu M, Shiomi S, Iwao H, Ochi H (2002) New bone-seeking agent: animal study of Tc-99m-incadronate. Ann Nucl Med 16:55–59
Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD (1975) Tc-99m-methylene diphosphonate-a superior agent for skeletal imaging: comparison with other Technetium complexes. J Nucl Med 16:744–755
Love C, Din AS, Tomas MB, Kalapparambath TP, Palestro CJ (2003) Radionuclide bone imaging: an illustrative review. RadioGraphics 23:341–358
Handeland Å, Lindegaard MW, Heggli D-E (1989) Biodistribution of anionic separated MDP complexes from different MDP preparations. Eur J Nucl Med 15:609–611
Ogawa K, Saji H (2011) Advances in drug design of radiometal-based imaging agents for bone disorders. Int J Mol Imaging 2011:537687
Meyer J, Nancollas G (1973) The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite. Calc Tissue Res 13:295–303
Verbeke K, Rozenski J, Cleynhens B, Vanbilloen H, de Groot T, Weyns N, Bormans G, Verbruggen A (2002) Development of a conjugate of 99mTc-EC with aminomethylenediphosphonate in the search for a bone tracer with fast clearance from soft tissue. Bioconjugate Chem 13:16–22
Ogawa K, Mukai T, Inoue Y, Ono M, Saji H (2006) Development of a novel 99mTc-chelate–conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent. J Nucl Med 47:2042–2047
Chadha N, Sinha D, Tiwari AK, Chuttani K, Mishra AK (2013) Synthesis, biological evaluation and molecular docking studies of high-affinity bone targeting N, N′-bis (alendronate) diethylenetriamene-N, N′-triacetic acid: a bifunctional bone scintigraphy agent. Chem Biol Drug Des 82:468–476
Senocak K, Teksoz S, Ichedef C, Ucar E (2015) Synthesis and biological evaluation of bisphosphonate compound labeled with 99mTc(CO) +3 . Chem Biol Drug Des 85:369–376
Palma E, Oliveira BL, Correia JD, Gano L, Maria L, Santos IC, Santos I (2007) A new bisphosphonate-containing 99mTc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation. J Biol Inorg Chem 12:667–679
Palma E, Correia JD, Oliveira BL, Gano L, Santos IC, Santos I (2011) 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging. Dalton Trans 40:2787–2796
Fernandes C, Monteiro S, Mendes P, Gano L, Marques F, Casimiro S, Costa L, Correia JDG, Santos I (2014) Biological assessment of novel bisphosphonate-containing 99mTc/Re-organometallic complexes. J Organomet Chem 760:197–204
Makris G, Tseligka ED, Pirmettis I, Papadopoulos MS, Vizirianakis IS, Papagiannopoulou D (2016) Development and pharmacological evaluation of new bone-targeted 99mTc-radiolabeled bisphosphonates. Mol Pharm 13:2301–2317
Banerjee S, Ambikalmajan Pillai MR, Ramamoorthy N (2001) Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med 31:260–277
Russell RGG, Rogers MJ (1999) Bisphosphonates: from the laboratory to the clinic and back again. Bone 25:97–106
Russell RGG (2006) Bisphosphonates. Ann N Y Acad Sci 1068:367–401
Ri M-H, Jang Y-M, Ri U-S, Yu C-J, Kim K-I, Kim S-U (2018) Ab initio investigation of adsorption characteristics of bisphosphonates on hydroxyapatite (001) surface. J Mater Sci 53:4252–4261
Lee OL, Horvath N, Lee C, Joshua D, Ho J, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Talaulikar D, Brown R, Augustson B, Ling S, Jaksic W, Gibson J, Kalff A, Johnston A, Kalro A, Ward C, Prince HM, Zannettino A (2017) Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Intern Med J 47:938–951
Zhang S, Zhang W, Wang Y, Jin Z, Wang X, Zhang J, Zhang Y (2011) Synthesis and biodistribution of a novel 99mTcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjugate Chem 22:369–375
Li Z, Zhang J, Jin Z, Zhang W, Zhang Y (2015) Synthesis and biodistribution of novel 99mTc labeled 4-nitroimidazole dithiocarbamate complexes as potential agents to target tumor hypoxia. Med Chem Commun 6:1143–1148
Liu T, Gan Q, Zhang J, Jin Z, Zhang W, Zhang Y (2016) Synthesis and biodistribution of novel 99mTcN complexes of glucose dithiocarbamate as potential probes for tumor imaging. Med Chem Commun 7:1381–1386
Liu M, Lin X, Song XQ, Cui Y, Li PW, Wang XB, Zhang JB (2013) Synthesis and biodistribution of a novel 99mTc nitrido radiopharmaceutical with proline dithiocarbamate as a potential tumor imaging agent. J Radioanal Nucl Chem 298:1659–1663
Zhu J, Fang S, Wang Y, Zhang J, Li Z (2014) Synthesis and biological evaluation of novel 99mTc-oxo and 99mTc-nitrido complexes with phenylalanine dithiocarbamate for tumor imaging. J Radioanal Nucl Chem 302:211–216
Song X, Wang Y, Zhang J, Jin Z, Zhang W, Zhang Y (2018) Synthesis and evaluation of a novel 99mTc nitrido radiopharmaceutical with alendronate dithiocarbamate as a potential bone-imaging agent. Chem Biol Drug Des 91:545–551
Bordoloi JK, Berry D, Khan IU, Sunassee K, de Rosales RTM, Shanahan C, Blower PJ (2015) 99mTc and 188Re complexes with one and two pendant bisphosphonate groups for imaging arterial calcification. Dalton Trans 44:4963–4975
Acknowledgements
The work was financially supported, in part, by National Natural Science Foundation of China (21771023).
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiaoqing Song and Yue Wang are joint first authors.
Rights and permissions
About this article
Cite this article
Song, X., Wang, Y. & Zhang, J. Influence of different 99mTc cores on the physicochemical and biodistribution behaviours of 99mTc-labelled complexes of pamidronate dithiocarbamate. J Radioanal Nucl Chem 316, 313–319 (2018). https://doi.org/10.1007/s10967-018-5727-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-018-5727-2